☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
tezacaftor
Vertex Receives the EMA’s CHMP Positive Opinion of Kaftrio (ivacaftor/tezacaftor/elexacaftor) + Ivacaftor Aged 6 Through 11Years w...
September 15, 2023
Top Performing Drug – Trikafta/Kaftrio (May Edition)
May 24, 2023
Insights+: The US FDA New Drug Approvals in April 2023
May 17, 2023
Vertex Receives the Health Canada Marketing Authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat C...
April 21, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.
